Potential role of S-adenosylmethionine in osteosarcoma development

Hui Shi,1,2,* Wei-dong Mu,1,* Bing Zhang,3 Tao Meng,2 Shou-tao Zhang,2 Dong-sheng Zhou1 1Department of Traumatic Orthopaedics, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 2Department of Bone and Joint Surgery, 3Department of Urology Surgery, Binzhou Medical University Hos...

Full description

Bibliographic Details
Main Authors: Shi H, Mu WD, Zhang B, Meng T, Zhang ST, Zhou DS
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/potential-role-of-s-adenosylmethionine-in-osteosarcoma-development-peer-reviewed-article-OTT
id doaj-adf1cdcdfef64b54ae6bfff14ac043cf
record_format Article
spelling doaj-adf1cdcdfef64b54ae6bfff14ac043cf2020-11-24T22:04:06ZengDove Medical PressOncoTargets and Therapy1178-69302016-06-012016Issue 13653365927518Potential role of S-adenosylmethionine in osteosarcoma developmentShi HMu WDZhang BMeng TZhang STZhou DSHui Shi,1,2,* Wei-dong Mu,1,* Bing Zhang,3 Tao Meng,2 Shou-tao Zhang,2 Dong-sheng Zhou1 1Department of Traumatic Orthopaedics, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 2Department of Bone and Joint Surgery, 3Department of Urology Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, People’s Republic of China *These authors contributed equally to this work Abstract: The metastatic form of osteosarcoma is a life threatening one since it metastasizes to the lungs. The major cause of metastatic osteosarcoma is hypomethylation of numerous genes that undergo overexpression to enable the progression of the disease. In the present study, S-adenosylmethionine (SAM), a predominant methyl donor, was administered to find out its effects on osteosarcoma progression. As evidence of tumor suppression, the SAM-treated mouse tissue was analyzed histologically, which exemplifies the control that SAM has over abnormal cell proliferation, especially on primary osteosarcoma, but it lacks positive effects on metastatic osteosarcoma. At the molecular level, the successful inhibition of primary osteosarcoma was found to be associated with a lower expression of Sox2, a protein highly expressed in osteosarcoma stem cells, along with an upregulated expression of TCTP. The data suggest that the administration of SAM has a positive role in treating primary osteosarcoma, but it has no role in suppressing metastatic osteosarcoma. The decreased expression of Sox2 together with upregulation of TCTP following SAM administration indicates that SAM has a control over primary osteosarcoma. Keywords: TCTP, S-adenosylmethionine, K7M2 cells, Sox2, BALB/c mousehttps://www.dovepress.com/potential-role-of-s-adenosylmethionine-in-osteosarcoma-development-peer-reviewed-article-OTTTCTPS-AdenosylmethionineK7M2 cellsSox2BALB/c mouse.
collection DOAJ
language English
format Article
sources DOAJ
author Shi H
Mu WD
Zhang B
Meng T
Zhang ST
Zhou DS
spellingShingle Shi H
Mu WD
Zhang B
Meng T
Zhang ST
Zhou DS
Potential role of S-adenosylmethionine in osteosarcoma development
OncoTargets and Therapy
TCTP
S-Adenosylmethionine
K7M2 cells
Sox2
BALB/c mouse.
author_facet Shi H
Mu WD
Zhang B
Meng T
Zhang ST
Zhou DS
author_sort Shi H
title Potential role of S-adenosylmethionine in osteosarcoma development
title_short Potential role of S-adenosylmethionine in osteosarcoma development
title_full Potential role of S-adenosylmethionine in osteosarcoma development
title_fullStr Potential role of S-adenosylmethionine in osteosarcoma development
title_full_unstemmed Potential role of S-adenosylmethionine in osteosarcoma development
title_sort potential role of s-adenosylmethionine in osteosarcoma development
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2016-06-01
description Hui Shi,1,2,* Wei-dong Mu,1,* Bing Zhang,3 Tao Meng,2 Shou-tao Zhang,2 Dong-sheng Zhou1 1Department of Traumatic Orthopaedics, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 2Department of Bone and Joint Surgery, 3Department of Urology Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, People’s Republic of China *These authors contributed equally to this work Abstract: The metastatic form of osteosarcoma is a life threatening one since it metastasizes to the lungs. The major cause of metastatic osteosarcoma is hypomethylation of numerous genes that undergo overexpression to enable the progression of the disease. In the present study, S-adenosylmethionine (SAM), a predominant methyl donor, was administered to find out its effects on osteosarcoma progression. As evidence of tumor suppression, the SAM-treated mouse tissue was analyzed histologically, which exemplifies the control that SAM has over abnormal cell proliferation, especially on primary osteosarcoma, but it lacks positive effects on metastatic osteosarcoma. At the molecular level, the successful inhibition of primary osteosarcoma was found to be associated with a lower expression of Sox2, a protein highly expressed in osteosarcoma stem cells, along with an upregulated expression of TCTP. The data suggest that the administration of SAM has a positive role in treating primary osteosarcoma, but it has no role in suppressing metastatic osteosarcoma. The decreased expression of Sox2 together with upregulation of TCTP following SAM administration indicates that SAM has a control over primary osteosarcoma. Keywords: TCTP, S-adenosylmethionine, K7M2 cells, Sox2, BALB/c mouse
topic TCTP
S-Adenosylmethionine
K7M2 cells
Sox2
BALB/c mouse.
url https://www.dovepress.com/potential-role-of-s-adenosylmethionine-in-osteosarcoma-development-peer-reviewed-article-OTT
work_keys_str_mv AT shih potentialroleofsadenosylmethionineinosteosarcomadevelopment
AT muwd potentialroleofsadenosylmethionineinosteosarcomadevelopment
AT zhangb potentialroleofsadenosylmethionineinosteosarcomadevelopment
AT mengt potentialroleofsadenosylmethionineinosteosarcomadevelopment
AT zhangst potentialroleofsadenosylmethionineinosteosarcomadevelopment
AT zhouds potentialroleofsadenosylmethionineinosteosarcomadevelopment
_version_ 1725830534072893440